Projected commercial pricing When Eli Lilly eventually brings retatrutide to market, likely in late 2027 or 2028, analysts project a list price of $1,000 to $1,500 per month based on comparable GLP-1 medications like Mounjaro and Ozempic
Retatrutide may eventually surpass it in terms of overall weight loss potential due to its triple-action approach, although responses vary from person to person
doi:10.1080/03007995.2018.1454417 57
A person can keep a log or mark a calendar to remember
However, the study highlighted a critical nuance: when assessed on a grams per kilogram of body weight per day (g/kg/day) basis, average protein intake was insufficient to meet the higher needs (1.22.0 g/kg/day) recommended during weight loss
10.3389/fpsyt.2018.00730 8 Al JowfG